Department of Preventive Medicine

Medicine & Life Sciences

1. Mutation 100%
2. Hereditary Nonpolyposis Colorectal Neoplasms 94%
3. Breast Neoplasms 88%
4. Neoplasms 62%
5. Colorectal Neoplasms 54%
6. Ovarian Neoplasms 38%
7. Germ-Line Mutation 35%
8. Genetic Counseling 31%
9. Hereditary Neoplastic Syndromes 24%
10. Pancreatic Neoplasms 23%
11. DNA Mismatch Repair 22%
12. Genes 21%
13. Colonic Neoplasms 20%
14. Ovariectomy 20%
15. Molecular Biology 19%
16. Endometrial Neoplasms 18%
17. Adenomatous Polyposis Coli 17%
18. Pedigree 16%
19. Familial Breast Cancer 15%
20. Microsatellite Instability 14%
21. Genetic Testing 12%
22. Carcinoma 11%
23. Neoplasm Genes 10%
24. Alleles 9%
25. Colectomy 9%
26. Dysplastic Nevus Syndrome 9%
27. Genetic Predisposition to Disease 9%
28. Incidence 9%
29. Stomach Neoplasms 9%
30. Natural History 9%
31. Tamoxifen 8%
32. Confidence Intervals 8%
33. Penetrance 8%
34. BRCA2 Gene 8%
35. Polyps 8%
36. Prophylactic Mastectomy 8%
37. Physicians 8%
38. Salpingo-oophorectomy 8%
39. Hereditary Breast and Ovarian Cancer Syndrome 8%
40. Adenoma 7%
41. Registries 7%
42. Risk Reduction Behavior 7%
43. DNA 7%
44. Population 7%
45. Colon 7%
46. BRCA1 Gene 7%
47. Attenuated familial adenomatous polyposis 7%
48. Early Detection of Cancer 7%
49. Case-Control Studies 7%
50. Lynch Syndrome II 7%
51. Carcinogenesis 7%
52. Multiple Myeloma 6%
53. Age of Onset 6%
54. Phenotype 6%
55. Genotype 6%
56. Odds Ratio 6%
57. Adenocarcinoma 6%
58. Melanoma 6%
59. Colonoscopy 6%
60. Ovary 5%
61. Survival 5%
62. Single Nucleotide Polymorphism 5%
63. Oral Contraceptives 5%
64. Chemoprevention 5%
65. Biomarkers 5%
66. Smoking 5%
67. Prospective Studies 5%
68. Nuclear Family 5%